This article is more than 5 years old. Information may no longer be current.
Boston type 1 keratoprosthesis produced favorable long-term outcomes
Click Here to Manage Email Alerts
Despite an increase in complications with longer follow-up, Boston type 1 keratoprosthesis was shown to have lasting positive effects during a 7-year period, according to study findings.
The retrospective study included 139 eyes of 133 patients who underwent Boston type 1 keratoprosthesis (KPro) implantation at five tertiary referral centers. Researchers analyzed visual acuity, postoperative complications and device retention outcomes for patients with at least one postoperative visit. Mean follow-up was 46.7 months.
Prior to undergoing KPro, only 10.8% of patients had a VA of 20/200 or better. VA improved to 20/200 or better in 70% of patients postoperatively, with a probability of 50% that these improvements would be maintained at 7-year follow-up.
The estimated retention rate for the device at 7 years was 67%, according to the researchers.
Among the postoperative complications reported, 7-year cumulative incidence was 49.7% for retroprosthetic membrane formation, 21.6% for glaucoma surgery, 18.6% for retinal detachment and 15.5% for endophthalmitis.
Disclosure: See the study for full list of all authors’ relevant financial disclosures.
Click Here to Manage Email Alerts